With a mission to support novel approaches to managing and preventing heart failure, the Ted Rogers Centre for Heart Research uses its Innovation Fund to propel emerging research with great potential. The 2024-25 Innovation Fund Seed Grants are currently open and you...
The Ted Rogers Centre for Heart Research is delighted to welcome Iris Cohn as the new Innovator in Genomic Translation - also recently promoted to Director of the Pharmacogenetics (PGx) Program at The Hospital for Sick Children. A trained pharmacist, Iris established...
NorthMiRs Inc., an innovative cardiovascular biotech start-up, has won $250,000 in funding from the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) PITCH 2024 competition. Since its launch in 2018, the ECHO...
Congenital heart disease (CHD) is the most commonly occurring birth anomaly. Despite a strong genetic basis, almost 90% of cases remain genetically undiagnosed. However, the surge of new technology is enabling a search for hidden gene defects not detectable on...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
The International Cardio-Oncology Society (IC-OS) is a committed group of professionals throughout the world who are striving to protect the cardiovascular health of all patients who are undergoing cancer therapy.
The Global Cardio-Oncology Summit will summarize the latest research and best practices in Cardio-Oncology, a multidisciplinary speciality that has gained a growing interest from a large number of healthcare providers including oncologists, cardiologists, radiologists, nurses, pharmacists, and basic scientists. Hand in hand with leading experts, G-COS aims is to improve our knowledge of the role of diagnostic and management tools to mitigate cardiotoxicity risk, while maintaining effective cancer therapies.
IC-OS invites abstract submmissions for the Global Cardio-Oncology Summit 2021 – Virtual on the prevention, management and treatment of cardiac complications related to oncology therapy. Deadline is 1st August 2021. For more info on registration, program and abstract submission details please click on this link.